Adjuvant medicines for the management of neuropathic pain.
The main focus of this article, part of a series on pain, is to describe the abnormal patterns that occur in persistent and neuropathic pain states. It provides an overview of the adjuvant medications available to treat this type of pain when it does not respond to conventional methods. Treatments described require the input of pain specialists; however, the purpose of this article is to encourage nurses to assess pain accurately and to identify symptoms of neuropathic pain, thereby improving patient outcomes.
St. Mary's Hospital, London. Katharine.stewart@imperial.nhs.uk
K
K
Stewart
D000277:Adjuvants, Pharmaceutic / Q000494:pharmacology / Q000627:therapeutic use*; D000779:Anesthetics, Local / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D009437:Neuralgia / Q000175:diagnosis / Q000188:drug therapy* / Q000451:nursing; D009730:Nursing Assessment; D010147:Pain Measurement; D018579:Patient Selection; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors
D000277:Adjuvants, Pharmaceutic; D000779:Anesthetics, Local; D000927:Anticonvulsants; D000929:Antidepressive Agents, Tricyclic; D016194:Receptors, N-Methyl-D-Aspartate; D002116:Calcitonin